VANCOUVER, British Columbia, November 3, 2016 /PRNewswire/ -- Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (" Reliq" or the " Company"), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Hamilton Health Sciences and McMaster University in Hamilton, ON to pilot its remote patient monitoring and care collaboration solution. The pilot is expected to commence in February 2017. "We are very excited to work with Hamilton Health Sciences (the " HHS") and McMaster University to improve health outcomes for patients with Peripheral Arterial Disease (the " PAD"). Our collaboration with McMaster and HHS will allow us to deliver a digital health solution for self-care and patient education that is uniquely tailored to the needs of PAD outpatients." said Dr. Lisa Crossley, CEO of Reliq Health. "Our platform uses a high tech, low touch approach to provide high quality healthcare in the home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction". Peripheral Arterial Disease affects over 800,000 Canadians and over 8 Million Americans. PAD can cause pain, fatigue, poor circulation and slow wound healing in the extremities. Unless properly managed, PAD can lead to significant complications including infection, gangrene and amputations. Reliq Health's proprietary hardware and software supports patients and their caregivers in the home, providing remote monitoring with alerts to clinicians as needed, audible reminders to improve patient compliance with prescribed medication regimens and lifestyle changes, tailored digital patient education materials and secure communication with the entire care team. Studies have consistently shown that providing patients and families with the tools they need to better understand and manage their clinical conditions at home leads to better health outcomes.